Does the Extent of Lymphadenectomy in Radical Cystectomy for Bladder Cancer Influence Disease-Free Survival? A Prospective Single-Center Study
|
|
- Samuel Burns
- 6 years ago
- Views:
Transcription
1 EUROPEAN UROLOGY 60 (2011) available at journal homepage: Bladder Cancer Does the Extent of Lymphadenectomy in Radical Cystectomy for Bladder Cancer Influence Disease-Free Survival? A Prospective Single-Center Study Hassan Abol-Enein a,1, Derya Tilki a,b,1, *, Ahmed Mosbah a, Mahmoud El-Baz c, Ahmed Shokeir a, Adel Nabeeh a, Mohamed A. Ghoneim a a Department of Urology, Urology and Nephrology Center, Mansoura University, Mansoura, Egypt; b Department of Urology, Ludwig-Maximilians-University, Klinikum Grosshadern, Munich, Germany; c Department of Pathology, Urology and Nephrology Center, Mansoura University, Mansoura, Egypt Article info Article history: Accepted May 31, 2011 Published online ahead of print on June 12, 2011 Keywords: Urinary bladder Urothelial carcinoma Extended lymphadenectomy Prognosis Abstract Background: Controversy exists regarding the optimal extent of lymphadenectomy and the number of lymph nodes to be retrieved at radical cystectomy (RC). Objective: To compare the disease-free survival of patients with standard lymphadenectomy (endopelvic region composed of the internal, external iliac, and obturator groups of lymph nodes) versus extended lymphadenectomy (up to the level of origin of the inferior mesenteric artery) at RC in a prospective cohort of patients at a single, high-volume center. Design, setting, and participants: Prospective data were collected from 400 consecutive patients treated with RC for bladder cancer by two high-volume surgeons at Mansoura Urology and Nephrology Center. Of the 400 patients, 200 (50%) received extended lymphadenectomy and the other 200 (50%) underwent standard lymphadenectomy at RC. The patients did not receive any neoadjuvant or adjuvant therapy. Measurements: Patient characteristics and outcomes are evaluated. Results and limitations: Median patient age for the entire group was 53.0 yr. Ninety-six patients (24.0%) had lymph node metastases. Median follow-up was 50.2 mo. Estimates of 5-yr disease-free survival in the extended lymphadenectomy group were 66.6% compared with 54.7% for patients with standard lymphadenectomy ( p = 0.043). Extended lymphadenectomy was associated with better disease-free survival after adjusting for the effects of standard pathologic features ( p = 0.02). When restricting the analyses to lymph node positive patients, patients with extended lymphadenectomy had much better 5-yr disease-free survival compared with patients with standard lymphadenectomy (48.0% vs 28.2%; p = 0.029). The study was nonrandomized. Conclusions: Extended lymphadenectomy is associated with better disease-free survival for bladder cancer patients with endopelvic lymph node involvement and should be considered in these patients. # 2011 European Association of Urology. Published by Elsevier B.V. All rights reserved. 1 Both authors contributed equally. * Corresponding author. Urology and Nephrology Center, Mansoura University, Mansoura, Egypt. Tel ; Fax: address: dtilki@me.com (D. Tilki) /$ see back matter # 2011 European Association of Urology. Published by Elsevier B.V. All rights reserved. doi: /j.eururo
2 EUROPEAN UROLOGY 60 (2011) Introduction For patients with muscle-invasive bladder cancer and for those with high-risk non muscle-invasive bladder cancer, radical cystectomy (RC) with bilateral pelvic lymphadenctomy provides accurate staging and adequate local and regional control [1 3]. Pathologic tumor (pt) category and lymph node status are the strongest prognostic factors in patients with bladder cancer [1 3]. Although the importance of lymphadenectomy in the management of muscle-invasive bladder cancer is beyond doubt, no consensus exists regarding the optimal extent of lymphadenectomy, the number of lymph nodes to be retrieved, and the procedure s prognostic and therapeutic role for patients with bladder cancer undergoing RC [4,5]. Recent studies have suggested that an extended lymphadenectomy leads to improved survival [6 13]; however, to a large extent, these studies were limited by their multicenter and retrospective natures with multiple surgeons and pathologists. Furthermore, most of these studies used lymph node count as a surrogate for extent of lymphadenectomy without unification of the field of lymphadenectomy [6 10,12,13]. To define the optimal extent of lymphadenectomy with cystectomy, we have previously performed a prospective patho-anatomical single-center study with a total of 200 patients who underwent RC and extended lymphadenectomy up to the level of origin of the inferior mesenteric artery [14]. We did not find skipped lesions, and we defined the endopelvic site composed of the internal, external iliac, and obturator groups of lymph nodes as a sentinel region, concluding that a more proximal dissection should be reserved for patients with positive lymph nodes in this region. The purpose of the current study was to evaluate the longterm disease-free survival outcome of these patients [14] and to compare it with that of patients with standard lymphadenectomy in a large, prospective, single-institution cohort. 2. Patients and methods 2.1. Patient selection This was an institutional review board approved, prospective, nonrandomized study. Preoperative patient evaluation included routine clinical assessment, bimanual examination under anesthesia, cystoscopy, and biopsy. Abdominal sonography, chest x-ray, and computed tomography with contrast material were done. Informed consent was obtained from all patients prior to surgery. Between 1999 and 2003, 400 consecutive patients with invasive bladder cancer were treated with RC and standard (n = 200) or extended (n = 200) lymphadenectomy at the Urology and Nephrology Center of Mansoura University. The 200 patients with extended lymphadenectomy have been previously analyzed in a patho-anatomical study [14]. The patients did not receive any neoadjuvant or adjuvant therapy Operation The procedure was performed by only two surgeons (HA-E, MAG), as described previously [14]. The proximal extent of lymphadenectomy was at the level of origin of the inferior mesenteric artery for the extended lymphadenectomy group [14] and at the level of the bifurcation of the common iliac vessels (distal inch of the common iliac artery) for the standard lymphadenectomy group, as described previously [15]. Extended lymphadenectomy was performed for study purposes [14] and is not routine in our current practice. The surgeon decided about the performance of an extended lymphadenectomy intraoperatively, depending on liver status. Body mass index, performance status, and clinical tumor stage and grade did not play a role Pathologic evaluation All surgical specimens were processed according to standard pathologic procedures by a single uropathologist. Harvested nodes were identified by visual inspection and/or tactile sensation. No fat clearing technique was done. The number of retrieved nodes per anatomical group was determined. Each detected node was sharply bisected, and multiple sections were obtained for histologic examination. The fixed bladder specimen was opened, and tissue sections from the tumor were obtained. The TNM classification was used for pathologic staging, and the World Health Organization classification was used for histologic typing and grading Follow-up Follow-up was performed according to our institutional protocol. In general, patients were seen postoperatively at least every 3 4 mo for the first year, semiannually for the second year, and annually thereafter. Follow-up visits consisted of physical examination and serum chemistry evaluation. Diagnostic imaging of the upper tracts and chest radiography were performed at least annually or when clinically indicated. Additional radiographic evaluation was performed at the discretion of the treating physician. When patients died, the cause of death was determined by the treating physicians, by chart review, by family interrogation, or by death certificates alone Statistical analysis Continuous variables were compared between groups using either the two-sample t test or the Wilcoxon rank-sum test; categoric variables were compared using the chi-square test. Disease-free survival was estimated by the Kaplan-Meier method, and differences were assessed with the log-rank statistic. The period of disease-free survival was defined as the time between the date of surgery and death (from cancer) or the development of local recurrence or distant metastasis. Death from an unknown cause was considered death from cancer. Censored survival values represent patients who were alive without clinical evidence of disease at last follow-up. Multivariate Cox proportional hazards regression analysis was used to study the simultaneous effects of prognostic factors on disease-free survival. All reported p values are twosided, and statistical significance was set at p < Statistical tests were performed with SPSS v (IBM Corp., Somers, NY, USA). 3. Results 3.1. Clinical and pathologic characteristics Four hundred patients with bladder cancer underwent RC with lymphadenectomy. Median age in the entire patient group was 53.0 yr (interquartile range [IQR]: 13.0). Of the 400 patients, 200 (50.0%) had standard lymphadenectomy and the other 200 (50.0%) received extended lymphadenectomy. The clinical and pathologic features for these patients
3 574 EUROPEAN UROLOGY 60 (2011) Table 1 Clinical and pathologic characteristics of 400 patients with standard versus extended lymphadenectomy at radical cystectomy Standard lymphadenectomy Extended lymphadenectomy p value No. of patients % No. of patients % Overall Age, yr, median (IQR) 50.5 (12.0) 55.0 (12.0) Age < > Gender Males Females Pathologic stage pt1 and/or CIS pt pt Grade < Histology TCC SCC Adenocarcinoma Other Lymph node status Negative Positive No. of lymph nodes removed, median (IQR) 16 (8.0) 49.0 (18.75) <0.001 CIS = carcinoma in situ; IQR = interquartile range; SCC = squamous cell carcinoma; TCC = transitional cell carcinoma. are compared in Table 1. Ninety-six of all patients (24.0%) had lymph node metastasis. There were no significant differences in gender, pathologic stage, histology, and proportion of lymph node positive patients between the groups (Table 1). Median age of patients with extended lymphadenectomy was significantly higher when compared with patients with standard lymphadenectomy (55.0 vs 50.5 yr; p = 0.013). As expected, patients with extended lymphadenectomy had a significantly higher lymph node count compared with patients with standard lymphadenectomy (49.0 vs 16.0 lymph nodes; p < 0.001), 3.2. Clinical outcomes Median follow-up was 50.2 mo (IQR: 69.0) for patients alive at last follow-up. Disease recurrence occurred in 141 patients (35.3%). In the extended lymphadenectomy group, a total of 85 patients (42.5%) were deceased at the time of analysis, including 59 patients (29.5%) who died of bladder cancer. In the standard lymphadenectomy group, a total of 90 patients (45%) were deceased at the time of analysis, including 73 patients (36.5%) who died of bladder cancer. In univariate analyses, age at time of RC, gender, grade, and histology (all p values >0.05) were not associated with disease-free survival. In multivariate analyses, pt category ( p < 0.001), lymph node involvement ( p < 0.001), and extended lymphadenectomy ( p = 0.02) were independently associated with disease-free survival (Table 2). When restricting analyses to the patients with transitional cell carcinoma (TCC), extended lymphadenectomy was still an independent predictor of disease-free survival in lymph node positive patients with TCC ( p = 0.01) but not in the whole group of patients with TCC ( p = 0.10). Five-year disease-free survival estimates in the extended lymphadenectomy group were 66.6% (95% confidence interval [CI], 60 73%) compared to 54.7% (95% CI, 48 61%) for patients with standard lymphadenectomy ( p =0.043) (Fig. 1a). The difference in survival did not remain significant when restricting analyses to lymph node negative patients (Fig. 1b). In contrast, lymph node positive patients with extended lymphadenectomy had much better 5-yr diseasefree survival when compared with patients with standard lymphadenectomy (48.0% vs 28.2%; p = 0.029) (Fig. 1c). Table 2 Multivariate analysis predicting disease-free survival in 400 bladder cancer patients Variable Multivariate analysis (stepwise backward elimination) HR 95% CI p value Pathologic category pt2 Referent pt <0.001 Lymph node involvement <0.001 Extended lymphdenectomy CI = confidence interval; HR = hazard ratio. *Age, gender, grade, and histology were nonsignificant variables.
4 [(Fig._1)TD$FIG] EUROPEAN UROLOGY 60 (2011) A 100 Whole patient group Number of patients at risk Disease-free Survival (%) p=0.043 Ext LAE: 66.6% Std LAE: 54.7% Years Ext LAE Std LAE Number of cumulative events Years Ext LAE Std LAE Time (years) B Disease-free Survival (%) LN negative patients Ext LAE: 72.3% p=0.238 Std LAE: 66.2% Number of patients at risk Years Std LAE Number of cumulative events Years Ext LAE Std LAE Time (years) C 100 LN positive patients Disease-free Survival (%) p=0.029 Ext LAE: 48.0% Std LAE: 28.2% Number of patients at risk Years Ext LAE Std LAE Number of cumulative events Years Ext LAE Std LAE Time (years) Fig. 1 (a) Probability estimates of disease-free survival in 400 patients with bladder cancer stratified by extent of lymphadectomy. Probability estimates of disease-free survival in (b) 304 patients with lymph node negative bladder cancer and (c) 96 patients with lymph node positive bladder cancer, stratified by extent of lymphadectomy. LN = lymph node; LAE = lymphadenectomy; ext = extended; std = standard. 4. Discussion Despite the considerably large body of literature regarding the impact of lymphadenectomy on the outcomes after RC in patients with bladder cancer, there are conflicting data on the required extent of lymphadenectomy and its possible therapeutic effect. At present, clear recommendations about the field or extent of lymphadenectomy are missing in the European Association of Urology guidelines [16]. Several studies have indicated that the number of lymph nodes removed is a prognostic factor in bladder cancer patients [6 10,12,13]. Although several groups defined a minimum number of lymph nodes to be removed to confer a survival benefit [9,10,12,13], Koppie et al reported that the probability of survival rises as the number of lymph node removed increases [8]. Lymph node density describes the ratio of positive lymph nodes to the total number of retrieved nodes [17,18]. In a
5 576 EUROPEAN UROLOGY 60 (2011) retrospective study, Herr found that cases with a ratio of 20% positive nodes after pelvic lymphadenectomy had significantly better survival than those with a ratio of >20% [17]. Stein et al analyzed their results with extended lymphadenectomy up to the aortic bifurcation and confirmed the prognostically relevant threshold of 20% [1]. However, the median number of nodes removed was 13 in the study by Herr [17] and 30 in the study by Stein et al [1]. Since then, lymph node density has been the subject of several reports, with wide variation in the number of retrieved nodes and different threshold values of lymph node density [19 21]. In our opinion, useful ratio-based lymph node staging would need a unified definition of the required extent of lymphadenectomy and an agreement on the optimal number of lymph nodes to be retrieved [22]. Only limited data are available regarding the impact of a defined anatomically extended lymphadenectomy on clinical outcome of bladder cancer patients. Poulsen et al compared extended lymph node dissection up to the aortic bifurcation and endopelvic lymph node dissection only [23]. The authors found that the extended dissection improved recurrence-free survival for patients with pt3 disease. Leissner et al reviewed their experience with extended lymphadenectomy up to the aortic bifurcation, but onethird of their cases were unfollowed [9]. They noted a significant survival advantage when 16 nodes were removed. Both studies were retrospective and lacked anatomic mapping of the retrieved lymph nodes [9,23]. Mills and associates reported their experience with lymph node positive patients treated by cystectomy and pelvic dissection up to the bifurcation of the common iliac arteries and found capsular infiltration to be the only independently significant prognostic factor [5]. Anatomic mapping of harvested lymph nodes was performed, but lymphadenectomy was limited to the pelvic lymph nodes [5,22]. As described, the number of lymphadenectomy studies from reputable centers is high, but to our knowledge, all have the inherent limitations of retrospective studies. The limits of lymphadenectomy were variable, and the mean numbers of retrieved nodes were different. Most studies involved multiple surgeons and pathologists, and this has most likely influenced results because the number of lymph nodes dissected is largely dependent on surgeon and pathologist [24,25]. To overcome the shortcomings of earlier studies, we performed a prospective, single-center study evaluating the impact of performance of a defined extended lymphadenectomy on disease-free survival. The operative procedure was performed by only two high-volume surgeons to subdue an operator-dependent variable. Specimens from individual anatomical regions were sent separately and were evaluated by a single uropathologist. We found that lymph node positive patients with standard lymphadenectomy had significantly worse 5-yr disease-free survival compared with lymph node positive patients who underwent extended lymphadenectomy (28.2% vs 48.0%). In multivariate analysis, extended lymphadenectomy was an independent prognostic factor for disease-free survival. These data support the conclusion that a considerable proportion of bladder cancer patients with nodal involvement can be cured by meticulous extended lymphadenectomy. To our knowledge, this is the first prospective, surgically controlled, single-center study with standardized pathologic work-up to evaluate the impact of an anatomically defined extended lymphadenectomy versus standard lymphadenectomy with regard to clinical outcome in bladder cancer patients. Debatable data exist regarding the distribution and spread of lymph node metastases in bladder cancer patients [4,14,26,27]. In our previous pathoanatomical study, we performed extended lymphadenectomy up to the level of origin of the inferior mesenteric artery to clarify the pattern of lymph node spread and the optimal extent of lymphadenectomy [14]. We showed that extrapelvic nodal metastasis was always associated with involvement of the obturator and/ or internal iliac nodes, suggesting that there were no skipped lesions. Thus we defined the endopelvic site as a sentinel region, concluding that a more proximal dissection should be reserved for patients with positive lymph nodes in this region [14]. This is supported by our present data showing no evidence of a difference in clinical outcomes of lymph node negative patients with extended versus standard lymphadenectomy. Several studies have documented that extended lymphadenectomy is not associated with increased morbidity [4,9,14,23,28]. Based on our previous [14] and present findings showing a possible disease-free survival advantage for the patients who underwent extended lymphadenectomy, we propose the following algorithm in our center: In case of suspicious or positive (frozen section) endopelvic lymph nodes, lymphadenectomy should be extended to the level of the aortic bifurcation. In patients with nonsuspicious endopelvic nodes, an extended lymphadenectomy is not necessary. Our study has important limitations. First and foremost are the limitations inherent in nonrandomized analyses. The surgeon decided about the performance of an extended lymphadenectomy, resulting in a possible selection bias. Theoretically, significant comorbidities might have led to more limited lymphadenectomy in a few patients compared with healthier patients. In this series, however, the only limiting factor for performance of extended lymphadenectomy was the patient s hepatic function. Furthermore, tumor recurrence was the primary focus of our study and is not affected by this. Another limitation is that our patient population consisted of 39.3% of patients with squamous cell carcinoma. However, it has been shown previously that the incidence of nodal disease and prognosis following cystectomy are independent of the tumor histology [29]. 5. Conclusions In this prospective, single-center cohort, we found that an anatomically defined extended lymphadenectomy up to the level of origin of the inferior mesenteric artery is associated with better disease-free survival for lymph node positive bladder cancer patients independent of
6 EUROPEAN UROLOGY 60 (2011) other clinicopathologic features. Our data suggest that nodal disease by frozen section in the endopelvic region (standard lymphadenectomy) necessitates dissection up to the aortic bifurcation. Author contributions: Derya Tilki had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. Study concept and design: Abol-Enein, Tilki, Ghoneim. Acquisition of data: Abol-Enein, Tilki, Mosbah, El-Baz, Shokeir, Nabeeh, Ghoneim. Analysis and interpretation of data: Abol-Enein, Tilki, Ghoneim. Drafting of the manuscript: Tilki, Abol-Enein. Critical revision of the manuscript for important intellectual content: Abol- Enein, Tilki, Ghoneim. Statistical analysis: Tilki, Abol-Enein. Obtaining funding: None. Administrative, technical, or material support: None. Supervision: Abol-Enein, Tilki, Ghoneim. Other (specify): None. Financial disclosures: I certify that all conflicts of interest, including specific financial interests and relationships and affiliations relevant to the subject matter or materials discussed in the manuscript (eg, employment/ affiliation, grants or funding, consultancies, honoraria, stock ownership or options, expert testimony, royalties, or patents filed, received, or pending), are the following: None. Funding/Support and role of the sponsor: None. References [1] Stein JP, Lieskovsky G, Cote R, et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol 2001;19: [2] Shariat SF, Palapattu GS, Karakiewicz PI, et al. Discrepancy between clinical and pathologic stage: impact on prognosis after radical cystectomy. Eur Urol 2007;51:137 51, discussion [3] Hautmann RE, Gschwend JE, de Petriconi RC, Kron M, Volkmer BG. Cystectomy for transitional cell carcinoma of the bladder: results of a surgery only series in the neobladder era. J Urol 2006;176:486 92, discussion [4] Leissner J, Ghoneim MA, Abol-Enein H, et al. Extended radical lymphadenectomy in patients with urothelial bladder cancer: results of a prospective multicenter study. J Urol 2004;171: [5] Mills RD, Turner WH, Fleischmann A, Markwalder R, Thalmann GN, Studer UE. Pelvic lymph node metastases from bladder cancer: outcome in 83 patients after radical cystectomy and pelvic lymphadenectomy. J Urol 2001;166: [6] DharNB, Klein EA, Reuther AM, ThalmannGN, MadersbacherS, Studer UE. Outcome after radical cystectomy with limited or extended pelvic lymph node dissection. J Urol 2008;179:873 8, discussion 878. [7] Herr HW, Bochner BH, Dalbagni G, Donat SM, Reuter VE, Bajorin DF. Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer. J Urol 2002;167: [8] Koppie TM, Vickers AJ, Vora K, Dalbagni G, Bochner BH. Standardization of pelvic lymphadenectomy performed at radical cystectomy: can we establish a minimum number of lymph nodes that should be removed? Cancer 2006;107: [9] Leissner J, Hohenfellner R, Thuroff JW, Wolf HK. Lymphadenectomy in patients with transitional cell carcinoma of the urinary bladder; significance for staging and prognosis. BJU Int 2000;85: [10] May M, Herrmann E, Bolenz C, et al. Association between the number of dissected lymph nodes during pelvic lymphadenectomy and cancer-specific survival in patients with lymph node-negative urothelial carcinoma of the bladder undergoing radical cystectomy. Ann Surg Oncol. In press. [11] Poulsen J, Krarup T. Pelvic lymphadenectomy (staging) in patients with bladder cancer laparoscopic versus open approach. Scand J Urol Nephrol Suppl 1995;172: [12] Wright JL, Lin DW, Porter MP. The association between extent of lymphadenectomy and survival among patients with lymph node metastases undergoing radical cystectomy. Cancer 2008;112: [13] Capitanio U, Suardi N, Shariat SF, et al. Assessing the minimum number of lymph nodes needed at radical cystectomy in patients with bladder cancer. BJU Int 2009;103: [14] Abol-Enein H, El-Baz M, Abd El-Hameed MA, Abdel-Latif M, Ghoneim MA. Lymph node involvement in patients with bladder cancer treated with radical cystectomy: a patho-anatomical study a single center experience. J Urol 2004;172: [15] Abdel-Latif M, Abol-Enein H, El-Baz M, Ghoneim MA. Nodal involvement in bladder cancer cases treated with radical cystectomy: incidence and prognosis. J Urol 2004;172:85 9. [16] Stenzl A, Cowan NC, De Santis M, et al. The updated EAU guidelines on muscle-invasive and metastatic bladder cancer. Eur Urol 2009;55: [17] Herr HW. Superiority of ratio based lymph node staging for bladder cancer. J Urol 2003;169: [18] Herr HW. The concept of lymph node density is it ready for clinical practice? J Urol 2007;177:1273 5, discussion [19] Kassouf W, Agarwal PK, Herr HW, et al. Lymph node density is superior to TNM nodal status in predicting disease-specific survival after radical cystectomy for bladder cancer: analysis of pooled data from MDACC and MSKCC. J Clin Oncol 2008;26: [20] Wiesner C, Salzer A, Thomas C, et al. Cancer-specific survival after radical cystectomy and standardized extended lymphadenectomy for node-positive bladder cancer: prediction by lymph node positivity and density. BJU Int 2009;104: [21] May M, Herrmann E, Bolenz C, et al. Lymph node density affects cancer-specific survival in patients with lymph node positive urothelial bladder cancer following radical cystectomy. Eur Urol 2011;59: [22] Ghoneim MA, Abol-Enein H. Lymphadenectomy with cystectomy: is it necessary and what is its extent? Eur Urol 2004;46: [23] Poulsen AL, Horn T, Steven K. Radical cystectomy: extending the limits of pelvic lymph node dissection improves survival for patients with bladder cancer confined to the bladder wall. J Urol 1998;160:2015 9, discussion [24] Herr HW. Extent of surgery and pathology evaluation has an impact on bladder cancer outcomes after radical cystectomy. Urology 2003;61: [25] Sharir S, Fleshner NE. Lymph node assessment and lymphadenectomy in bladder cancer. J Surg Oncol 2009;99: [26] El-Shazli S, Anwar H, Ramzy S, Al-Didi M. Extended lymphadenectomy to the lower paraaortic nodes during radical cystectomy. J Egypt Natl Canc Inst 2004;16:22 8. [27] Vazina A, Dugi D, Shariat SF, Evans J, Link R, Lerner SP. Stage specific lymph node metastasis mapping in radical cystectomy specimens. J Urol 2004;171: [28] Brossner C, Pycha A, Toth A, Mian C, Kuber W. Does extended lymphadenectomy increase the morbidity of radical cystectomy? BJU Int 2004;93:64 6. [29] Ghoneim MA, Abdel-Latif M, el-mekresh M, et al. Radical cystectomy for carcinoma of the bladder: 2,720 consecutive cases 5 years later. J Urol 2008;180:121 7.
Lymphadenectomy with Cystectomy: Is It Necessary
European Urology European Urology 46 (2004) 457 461 Lymphadenectomy with Cystectomy: Is It Necessary and What Is Its Extent? Mohamed A. Ghoneim *, Hassan Abol-Enein Urology & Nephrology Center, Gomhouria
More informationLymph Node Positive Bladder Cancer Treated With Radical Cystectomy and Lymphadenectomy: Effect of the Level of Node Positivity
EUROPEAN UROLOGY 61 (2012) 1025 1030 available at www.sciencedirect.com journal homepage: www.europeanurology.com Bladder Cancer Lymph Node Positive Bladder Cancer Treated With Radical Cystectomy and Lymphadenectomy:
More informationDoes skip metastasis or other lymph node parameters have additional effects on survival of patients undergoing radical cystectomy for bladder cancer?
Original Article - Urological Oncology Korean J Urol 2015;56:357-364. pissn 2005-6737 eissn 2005-6745 Does skip metastasis or other lymph node parameters have additional effects on survival of patients
More informationA Fourteen-Year Review of Radical Cystectomy for Transitional Cell Carcinoma Demonstrating the Usefulness of the Concept of Lymph Node Density
Clinical Urology TCC of the Bladder and Lymph Node Density International Braz J Urol Vol. 32 (5): 536-549, September - October, 2006 A Fourteen-Year Review of Radical Cystectomy for Transitional Cell Carcinoma
More information346
EXTENDED LYMPHADENECTOMY IN BLADDER CANCER DURING RADICAL CYSTECTOMY: BENEFIT AND MORBIDITY Islam Mohiedden M, Diab El-Sayed M, Reda Mohamed S, Saad A M Al Qady, Department of Urology, Zagazig University,
More informationThe Predictors of Local Recurrence after Radical Cystectomy in Patients with Invasive Bladder Cancer
The Predictors of Local Recurrence after Radical Cystectomy in Patients with Invasive Bladder Cancer Hiroki Ide, Eiji Kikuchi, Akira Miyajima, Ken Nakagawa, Takashi Ohigashi, Jun Nakashima and Mototsugu
More informationRadical Cystectomy in the Treatment of Bladder Cancer: Oncological Outcome and Survival Predictors
ORIGINAL ARTICLE Radical Cystectomy in the Treatment of Bladder Cancer: Oncological Outcome and Survival Predictors Chen-Hsun Ho, 1,2 Chao-Yuan Huang, 1 Wei-Chou Lin, 3 Shih-Chieh Chueh, 1 Yeong-Shiau
More informationConclusions. Keywords
Outcomes of radical cystectomy with extended lymphadenectomy alone in patients with lymph node-positive bladder cancer who are unfit for or who decline adjuvant chemotherapy Pascal Zehnder*, Urs E. Studer,
More informationRadical Cystectomy Often Too Late? Yes, But...
european urology 50 (2006) 1129 1138 available at www.sciencedirect.com journal homepage: www.europeanurology.com Editorial 50th Anniversary Radical Cystectomy Often Too Late? Yes, But... Urs E. Studer
More informationRadical Cystectomy for Urothelial Carcinoma of the Bladder Without Neoadjuvant or Adjuvant Therapy: Long-Term Results in 1100 Patients
EUROPEAN UROLOGY 61 (2012) 1039 1047 available at www.sciencedirect.com journal homepage: www.europeanurology.com Bladder Cancer Radical Cystectomy for Urothelial Carcinoma of the Bladder Without Neoadjuvant
More informationRole of Pelvic Lymphadenectomy in the Treatment of Bladder Cancer: A Mini Review
www.kjurology.org DOI:10.4111/kju.2010.51.6.371 Review Article Role of Pelvic Lymphadenectomy in the Treatment of Bladder Cancer: A Mini Review Ja Hyeon Ku Department of Urology, Seoul National University
More informationRadical cystectomy for bladder cancer: oncologic outcome in 271 Chinese patients
Original Article : oncologic outcome in 271 Chinese patients Zhi-Ling Zhang, Pei Dong, Yong-Hong Li, Zhuo-Wei Liu, Kai Yao, Hui Han, Zi-Ke Qin and Fang-Jian Zhou Abstract Few large scale studies have reported
More informationExtranodal Extension Is a Powerful Prognostic Factor in Bladder Cancer Patients with Lymph Node Metastasis
EUROPEAN UROLOGY 64 (2013) 837 845 available at www.sciencedirect.com journal homepage: www.europeanurology.com Bladder Cancer Extranodal Extension Is a Powerful Prognostic Factor in Bladder Cancer Patients
More informationClinical Nodal Staging Scores for Bladder Cancer: A Proposal for Preoperative Risk Assessment
EUROPEAN UROLOGY 61 (2012) 237 242 available at www.sciencedirect.com journal homepage: www.europeanurology.com Platinum Priority Bladder Cancer Editorial by Alexandre R. Zlotta on pp. 243 244 of this
More informationClinical Outcomes of Patients with pt0 Bladder Cancer after Radical Cystectomy: A Single-institute Experience
Clinical Outcomes of Patients with pt0 Bladder Cancer after Radical Cystectomy: A Single-institute Experience Fumimasa Fukuta, Naoya Masumori *, Ichiya Honma, Masatoshi Muto, Koji Ichihara, Hiroshi Kitamura
More informationLymph node dissection: how much is enough?
1 Background Lymph node dissection: how much is enough? Eila C. Skinner, MD Professor of Clinical Urology USC Keck School of Medicine Radical cystectomy is the gold standard for the treatment of invasive
More informationReview Article Lymphadenectomy in Management of Invasive Bladder Cancer
Hindawi Publishing Corporation International Journal of Surgical Oncology Volume 2011, Article ID 758189, 9 pages doi:10.1155/2011/758189 Review Article Lymphadenectomy in Management of Invasive Bladder
More informationNodal staging and lymphadenectomy in patients undergoing radical cystectomy
37 Artigos Internacionais Nodal staging and lymphadenectomy in patients undergoing radical cystectomy Fredrik Liedberg, Wiking Månsson Department of Urology, Lund University Hospital, Lund, Sweden Introduction
More informationWe are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors
We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists 3,500 108,000 1.7 M Open access books available International authors and editors Downloads Our
More informationThe Role of Pelvic Lymph Node Dissection During Radical Cystectomy for Bladder Cancer
Short Review The Role of Pelvic Lymph Node Dissection During Radical Cystectomy for Bladder Cancer EUGENIO BRUNOCILLA, REMIGIO PERNETTI and GIUSEPPE MARTORANA Department of Urology, University of Bologna,
More informationLymph Node Density Affects Cancer-Specific Survival in Patients with Lymph Node Positive Urothelial Bladder Cancer Following Radical Cystectomy
EUROPEAN UROLOGY 59 (2011) 712 718 available at www.sciencedirect.com journal homepage: www.europeanurology.com Platinum Priority Bladder Cancer Editorial by James W.F. Catto on pp. 719 720 of this issue
More informationEUROPEAN UROLOGY 60 (2011)
EUROPEAN UROLOGY 60 (2011) 946 952 available at www.sciencedirect.com journal homepage: www.europeanurology.com Platinum Priority Bladder Cancer Editorial by Simon P. Kim and R. Jeffrey Karnes on pp. 953
More informationLymphadenectomy in Invasive Bladder Cancer: Knowns and Unknowns Seth P. Lerner, MD, FACS Professor of Urology Beth and Dave Swalm Chair in Urologic
Lymphadenectomy in Invasive Bladder Cancer: Knowns and Unknowns Seth P. Lerner, MD, FACS Professor of Urology Beth and Dave Swalm Chair in Urologic Oncology Scott Department of Urology Baylor College of
More informationSang Eun Lee, Hakmin Lee, Hyun Hwan Sung, Seong Il Seo, Seong Soo Jeon, Hyun Moo Lee, Han-Yong Choi, Byong Chang Jeong
Korean J Urol Oncol 2016;14(3):124129 Original Article Comparisons between Standard and Extended Pelvic Lymph Node Dissections During Radical Cystectomy in Patients with Bladder Cancer: Emphasis on Staging
More informationMUSCLE - INVASIVE AND METASTATIC BLADDER CANCER
10 MUSCLE - INVASIVE AND METASTATIC BLADDER CANCER Recommendations from the EAU Working Party on Muscle Invasive and Metastatic Bladder Cancer G. Jakse (chairman), F. Algaba, S. Fossa, A. Stenzl, C. Sternberg
More informationBone Metastases in Muscle-Invasive Bladder Cancer
Journal of the Egyptian Nat. Cancer Inst., Vol. 18, No. 3, September: 03-08, 006 AZZA N. TAHER, M.D.* and MAGDY H. KOTB, M.D.** The Departments of Radiation Oncology* and Nuclear Medicine**, National Cancer
More informationImpact of adjuvant chemotherapy on patients with pathological Stage T3b and/or lymph node metastatic bladder cancer after radical cystectomy
Japanese Journal of Clinical Oncology, 2015, 45(10) 963 967 doi: 10.1093/jjco/hyv098 Advance Access Publication Date: 29 July 2015 Original Article Original Article Impact of adjuvant chemotherapy on patients
More informationMUSCLE-INVASIVE AND METASTATIC BLADDER CANCER
MUSCLE-INVASIVE AND METASTATIC BLADDER CANCER (Text update March 2008) A. Stenzl (chairman), N.C. Cowan, M. De Santis, G. Jakse, M. Kuczyk, A.S. Merseburger, M.J. Ribal, A. Sherif, J.A. Witjes Introduction
More informationOde to a node Lymph node dissec3on in prostate and bladder cancer
5/26/10 Ode to a node Lymph node dissec3on in prostate and bladder cancer Anthony Koupparis 1 Introduc3on prostate cancer PLND most accurate and reliable staging method for LNI Imaging techniques have
More informationExtent of Pelvic Lymph Node Dissection During Radical Cystectomy: Is Bigger Better?
ManageMent Review Extent of Pelvic Lymph Node Dissection During Radical Cystectomy: Is Bigger Better? Debasish Sundi, MD, 1 Robert S. Svatek, MD, MSCI, 2 Matthew E. Nielsen, MD, MS, 3 Mark P. Schoenberg,
More informationLymphadenectomy at the Time of Nephroureterectomy for Upper Tract Urothelial Cancer
EUROPEAN UROLOGY 60 (2011) 776 783 available at www.sciencedirect.com journal homepage: www.europeanurology.com Collaborative Review Urothelial Cancer Lymphadenectomy at the Time of Nephroureterectomy
More informationResearch Article Partial Cystectomy after Neoadjuvant Chemotherapy: Memorial Sloan Kettering Cancer Center Contemporary Experience
International Scholarly Research Notices, Article ID 702653, 6 pages http://dx.doi.org/10.1155/2014/702653 Research Article Partial Cystectomy after Neoadjuvant Chemotherapy: Memorial Sloan Kettering Cancer
More informationWhen to Integrate Surgery for Metatstatic Urothelial Cancers
When to Integrate Surgery for Metatstatic Urothelial Cancers Wade J. Sexton, M.D. Senior Member and Professor Department of Genitourinary Oncology Moffitt Cancer Center Case Presentation #1 67 yo male
More informationUpdate on Sentinel Node Biopsy in Endometrial Cancer: Feasibility, Technique, Impact
Update on Sentinel Node Biopsy in Endometrial Cancer: Feasibility, Technique, Impact Bjørn Hagen, MD, PhD St Olavs Hospital Trondheim University Hospital Trondheim, Norway Endometrial Cancer (EC) The most
More informationA comparison of preliminary oncologic outcome and postoperative complications between patients undergoing either open or robotic radical cystectomy
ORIGINAL ARTICLE Vol. 42 (4): 663-670, July - August, 2016 doi: 10.1590/S1677-5538.IBJU.2015.0393 A comparison of preliminary oncologic outcome and postoperative complications between patients undergoing
More informationINVASIVE BLADDER CANCER
INVASIVE BLADDER CANCER - Aspects on staging and prognosis Liedberg, Fredrik 2006 Link to publication Citation for published version (APA): Liedberg, F. (2006). INVASIVE BLADDER CANCER - Aspects on staging
More informationUpper urinary tract urothelial carcinomas (UTUC)
Prognostic Role of Lymphovascular Invasion in Patients with Urothelial Carcinoma of the Upper Urinary Tract Manel Mellouli 1 *, Slim Charfi 1, Walid Smaoui 2, Rim Kallel 1, Abdelmajid Khabir 1, Mehdi Bouacida
More informationClinical Study of G3 Superficial Bladder Cancer without Concomitant CIS Treated with Conservative Therapy
Jpn J Clin Oncol 2002;32(11)461 465 Clinical Study of G3 Superficial Bladder Cancer without Concomitant CIS Treated with Conservative Therapy Takashi Saika, Tomoyasu Tsushima, Yasutomo Nasu, Ryoji Arata,
More informationRole and extension of lymph node dissection in kidney, bladder and prostate cancer. Omar Ghanem (PGY3 ) Moderator: Dr A. Noujem 30 th March 2017
Role and extension of lymph node dissection in kidney, bladder and prostate cancer Omar Ghanem (PGY3 ) Moderator: Dr A. Noujem 30 th March 2017 Bladder Cancer LN dissection in Bladder cancer 25% of patients
More informationThe Extent of Lymphadenectomy at the Time of Radical Cystectomy for Bladder Cancer and its Impact on Prognosis and Survival
Review Article TheScientificWorldJOURNAL (2005) 5, 891 901 ISSN 1537-744X; DOI 10.1100/tsw.2005.115 The Extent of Lymphadenectomy at the Time of Radical Cystectomy for Bladder Cancer and its Impact on
More informationDo Patients Benefit from Routine Follow-up to Detect Recurrences After Radical Cystectomy and Ileal Orthotopic Bladder Substitution?
EUROPEAN UROLOGY 58 (2010) 486 494 available at www.sciencedirect.com journal homepage: www.europeanurology.com Platinum Priority Bladder Cancer Editorial by Renzo Colombo on pp. 495 497 of this issue
More informationAnterior urethra sparing cystoprostatectomy for bladder cancer: a 10 year, single center experience
DOI 10.1186/s40064-015-1200-7 RESEARCH Open Access Anterior urethra sparing cystoprostatectomy for bladder cancer: a 10 year, single center experience Nozomi Hayakawa 1,2*, Nobuyuki Kikuno 1,2, Hiroki
More informationNeoadjuvant vs. Adjuvant Chemotherapy for Muscle-Invasive Bladder Cancer
Neoadjuvant vs. Adjuvant Chemotherapy for Muscle-Invasive Bladder Cancer Andrew J. Stephenson, MD, FRCSC, FACS Director, Urologic Oncology Associate Professor of Surgery Glickman Urological and Kidney
More informationORIGINAL ARTICLE. World J Urol (2011) 29: DOI /s
World J Urol (2011) 29:487 494 DOI 10.1007/s00345-011-0645-8 ORIGINAL ARTICLE Concomitant carcinoma in situ as an independent prognostic parameter for recurrence and survival in upper tract urothelial
More informationEarly radical cystectomy in NMIBC Marko Babjuk
Early radical cystectomy in NMIBC Marko Babjuk Dept. of Urology, 2nd Faculty of Medicine, Hospital Motol, Praha, Czech Republic We Are The European Association of Urology We Are Urologists, residents,
More informationDevelopment and external validation of nomograms predicting disease-free and cancer-specific survival after radical cystectomy
Development and external validation of nomograms predicting disease-free and cancer-specific survival after radical cystectomy Giuseppe Simone, Marco Bianchi, Diana Giannarelli, Siamak Daneshmand, Rocco
More informationBJUI. 35% had lymph node involvement at radical cystectomy or subsequent recurrence within the dissection template.
2010 THE AUTHORS; 2010 Urological Oncology LYMPH NODE STATUS IN PT0 BLADDER CANCER KAAG ET AL. BJUI Regional lymph node status in patients with bladder cancer found to be pathological stage T0 at radical
More informationPrognostic Factors for Survival of Stage IB Upper Lobe Non-small Cell Lung Cancer Patients: A Retrospective Study in Shanghai, China
www.springerlink.com Chin J Cancer Res 23(4):265 270, 2011 265 Original Article Prognostic Factors for Survival of Stage IB Upper Lobe Non-small Cell Lung Cancer Patients: A Retrospective Study in Shanghai,
More informationThe Feasibility of Robot-Assisted Laparoscopic Radical Cystectomy with Pelvic Lymphadenectomy: from the Viewpoint of Extended Pelvic Lymphadenectomy
The Feasibility of Robot-Assisted Laparoscopic Radical Cystectomy with Pelvic Lymphadenectomy: from the Viewpoint of Extended Pelvic Lymphadenectomy Seung Chul Kang, Sung Gu Kang, Hoon Choi, Young Hwii
More informationSignificance of the lymph nodes in the 7th station in rational dissection for metastasis of distal gastric cancer with different T categories
Original Article Significance of the lymph nodes in the 7th station in rational dissection for metastasis of distal gastric cancer with different T categories Wu Song, Yulong He, Shaochuan Wang, Weiling
More informationEvaluation of prognostic factors after radical prostatectomy in pt3b prostate cancer patients in Japanese population
Japanese Journal of Clinical Oncology, 2015, 45(8) 780 784 doi: 10.1093/jjco/hyv077 Advance Access Publication Date: 15 May 2015 Original Article Original Article Evaluation of prognostic factors after
More informationNumber of Metastatic Lymph Nodes in Resected Non Small Cell Lung Cancer Predicts Patient Survival
Number of Metastatic Lymph Nodes in Resected Non Small Cell Lung Cancer Predicts Patient Survival Jin Gu Lee, MD, Chang Young Lee, MD, In Kyu Park, MD, Dae Joon Kim, MD, Seong Yong Park, MD, Kil Dong Kim,
More informationwas performed to identify independent predictors of survival.
. JOURNAL COMPILATION 2010 Laparoscopic and Robotic Urology EARLY OUTCOMES FOR BUC PATIENTS TREATED WITH RRC KAUFFMAN ET AL. BJUI Early oncological outcomes for bladder urothelial carcinoma patients treated
More informationComparative Outcomes of Primary, Recurrent, and Progressive High-risk Non muscle-invasive Bladder Cancer
EUROPEAN UROLOGY 63 (2013) 145 154 available at www.sciencedirect.com journal homepage: www.europeanurology.com Platinum Priority Urothelial Cancer Editorial by J. Alfred Witjes on pp. 155 157 of this
More informationInvasive Bladder Transitional Cell Carcinoma OBJECTIVES
Invasive Bladder Transitional Cell Carcinoma UBC Urology Grand Rounds 7 September 2005 John Morrell R5 OBJECTIVES Review role of lymphadenectomy Review role of chemotherapy Review results of bimodal bladder
More informationRare Small Cell Carcinoma in Genitourinary Tract: Experience from E-Da Hospital
E-Da Medical Journal 20;():-5 Original Article Rare Small Cell Carcinoma in Genitourinary Tract: Experience from E-Da Hospital Wei-Ting Kuo, I-Wei Chang2, Kevin Lu, Hua-Pin Wang, Tsan-Jung u, Victor C.
More informationRadical cystectomy with pelvic lymphadenectomy: pathologic, operative and morbidity outcomes in a Brazilian cohort
ORIGINAL ARTICLE Vol. 42 (3): 431-437, May - June, 2016 doi: 10.1590/S1677-5538.IBJU.2015.0380 Radical cystectomy with pelvic lymphadenectomy: pathologic, operative and morbidity outcomes in a Brazilian
More informationRobotic assisted pelvic lymph node dissection for prostate cancer: frequency of nodal metastases and oncological outcomes
UROLCHI World J Urol DOI 10.1007/s00345-015-1515-6 ORIGINAL ARTICLE Robotic assisted pelvic lymph node dissection for prostate cancer: frequency of nodal metastases and oncological outcomes Rodrigo A.
More informationOptimal Timing of Radical Cystectomy for Patients with Invasive Transitional Cell Carcinoma of the Bladder
Jpn J Clin Oncol 2002;32(1)14 18 Optimal Timing of Radical Cystectomy for Patients with Invasive Transitional Cell Carcinoma of the Bladder Isao Hara, Hideaki Miyake, Shoji Hara, Akinobu Gotoh, Hiroshi
More informationLymphadenectomy in RCC: Yes, No, Clinical Trial?
Lymphadenectomy in RCC: Yes, No, Clinical Trial? Viraj Master MD PhD FACS Professor Associate Chair for Clinical Affairs and Quality Director of Clinical Research Unit Department of Urology Emory University
More informationLymph node ratio as a prognostic factor in stage III colon cancer
Lymph node ratio as a prognostic factor in stage III colon cancer Emad Sadaka, Alaa Maria and Mohamed El-Shebiney. Clinical Oncology department, Faculty of Medicine, Tanta University, Egypt alaamaria1@hotmail.com
More informationPeritoneal Involvement in Stage II Colon Cancer
Anatomic Pathology / PERITONEAL INVOLVEMENT IN STAGE II COLON CANCER Peritoneal Involvement in Stage II Colon Cancer A.M. Lennon, MB, MRCPI, H.E. Mulcahy, MD, MRCPI, J.M.P. Hyland, MCh, FRCS, FRCSI, C.
More informationEUROPEAN UROLOGY 61 (2012)
EUROPEAN UROLOGY 61 (2012) 480 487 available at www.sciencedirect.com journal homepage: www.europeanurology.com Platinum Priority Prostate Cancer Editorial by A. Heidenreich on pp. 488 490 of this issue
More informationTCC recurrence within the upper tract urothelium following
Upper Tract Urothelial Recurrence Following Radical Cystectomy for Transitional Cell Carcinoma of the Bladder: An Analysis of 1,069 Patients With 10-Year Followup Kristin M. Sanderson,* Jie Cai, Gustavo
More informationNIH Public Access Author Manuscript World J Urol. Author manuscript; available in PMC 2012 February 1.
NIH Public Access Author Manuscript Published in final edited form as: World J Urol. 2011 February ; 29(1): 11 14. doi:10.1007/s00345-010-0625-4. Significance of preoperative PSA velocity in men with low
More informationUrology Department, Inselspital, Bern, Switzerland. Key Words. Extended pelvic lymph node dissection Bladder cancer Prostate cancer
The Oncologist The Oncologist CME Program is located online at http://cme.theoncologist.com/. To take the CME activity related to this article, you must be a registered user. Genitourinary Cancer Indications,
More informationeuropean urology 55 (2009)
european urology 55 (2009) 261 270 available at www.sciencedirect.com journal homepage: www.europeanurology.com Platinum Priority Prostate Cancer Editorial by George N. Thalmann on pp. 271 272 of this
More informationPure non-bilharzial squamous cell carcinoma: An unusual form of carcinoma of the bladder
Safini et al. 31 case Series report peer Reviewed open OPEN ACCESS Pure non-bilharzial squamous cell carcinoma: An unusual form of carcinoma of the bladder Fatima Safini, Hassan Jouhadi, Meriem Elbachiri,
More informationIntra-operative frozen section analysis of common iliac lymph nodes in patients with stage IB1 and IIA1 cervical cancer
Arch Gynecol Obstet (2012) 285:811 816 DOI 10.1007/s00404-011-2038-z GYNECOLOGIC ONCOLOGY Intra-operative frozen section analysis of common iliac lymph nodes in patients with stage IB1 and IIA1 cervical
More informationThe Efficacy of Adjuvant Chemotherapy for Locally Advanced Upper Tract Urothelial Cell Carcinoma
Ivyspring International Publisher Research Paper 686 Journal of Cancer 2013; 4(8): 686-690. doi: 10.7150/jca.7326 The Efficacy of Adjuvant Chemotherapy for Locally Advanced Upper Tract Urothelial Cell
More informationInfluence of stage discrepancy on outcome in. in patients treated with radical cystectomy.
Tumori, 96: 699-703, 2010 Influence of stage discrepancy on outcome in patients treated with radical cystectomy Ja Hyeon Ku 1, Kyung Chul Moon 2, Cheol Kwak 1, and Hyeon Hoe Kim 1 1 Department of Urology,
More informationHydronephrosis as a Prognostic Marker in Bladder Cancer in a Cystectomy-Only Series
european urology 51 (2007) 690 698 available at www.sciencedirect.com journal homepage: www.europeanurology.com Bladder Cancer Hydronephrosis as a Prognostic Marker in Bladder Cancer in a Cystectomy-Only
More informationSuperior and Basal Segment Lung Cancers in the Lower Lobe Have Different Lymph Node Metastatic Pathways and Prognosis
ORIGINAL ARTICLES: Superior and Basal Segment Lung Cancers in the Lower Lobe Have Different Lymph Node Metastatic Pathways and Prognosis Shun-ichi Watanabe, MD, Kenji Suzuki, MD, and Hisao Asamura, MD
More informationLong-term Follow-up for Patients with Papillary Thyroid Carcinoma Treated as Benign Nodules
Long-term Follow-up for Patients with Papillary Thyroid Carcinoma Treated as Benign Nodules YASUHIRO ITO, TAKUYA HIGASHIYAMA, YUUKI TAKAMURA, AKIHIRO MIYA, KAORU KOBAYASHI, FUMIO MATSUZUKA, KANJI KUMA
More informationThe Depth of Tumor Invasion is Superior to 8 th AJCC/UICC Staging System to Predict Patients Outcome in Radical Cystectomy.
30 th Congress of the European Society of Pathology Tuesday, September 11, 2018 The Depth of Tumor Invasion is Superior to 8 th AJCC/UICC Staging System to Predict Patients Outcome in Radical Cystectomy.
More informationImplications of Progesterone Receptor Status for the Biology and Prognosis of Breast Cancers
日大医誌 75 (1): 10 15 (2016) 10 Original Article Implications of Progesterone Receptor Status for the Biology and Prognosis of Breast Cancers Naotaka Uchida 1), Yasuki Matsui 1), Takeshi Notsu 1) and Manabu
More informationChapter 2: Initial treatment for endometrial cancer (including histologic variant type)
Chapter 2: Initial treatment for endometrial cancer (including histologic variant type) CQ01 Which surgical techniques for hysterectomy are recommended for patients considered to be stage I preoperatively?
More informationIs There a Need to Further Subclassify pt2 Renal Cell Cancers as Implemented by the Revised 7th TNM Version?
EUROPEAN UROLOGY 59 (2011) 258 263 available at www.sciencedirect.com journal homepage: www.europeanurology.com Kidney Cancer Is There a Need to Further Subclassify pt2 Renal Cell Cancers as Implemented
More informationEvaluation of regional lymph node dissection in patients with upper urinary tract urothelial cancer
International Journal of Urology (2007) 4, 26 32 doi: 0./j.442-2042.2006.0664.x Evaluation of regional lymph node dissection in patients with upper urinary tract urothelial cancer Fernando P Secin, Theresa
More informationCURRICULUM VITAE ******* : Mohamed Abd Elhameed Abd Elhameed Date of birth : May 4, 1971.
CURRICULUM VITAE ******* Name : Mohamed Abd Elhameed Abd Elhameed Date of birth : May 4, 1971. Nationality : Egyptian Social status : Married Current post : Resident of Pathology, Urology&Nephrology Center,
More informationYASUHIDE KITAGAWA, KOUJI IZUMI, SOTARO MIWA, YOSHIFUMI KADONO, HIROYUKI KONAKA, ATSUSHI MIZOKAMI and MIKIO NAMIKI
Retrospective Analysis of the Efficacy of Two Cycles of M-VAC Neoadjuvant Chemotherapy Followed by Radical Cystectomy for Muscle-invasive Bladder Cancer YASUHIDE KITAGAWA, KOUJI IZUMI, SOTARO MIWA, YOSHIFUMI
More informationLung cancer is a major cause of cancer deaths worldwide.
ORIGINAL ARTICLE Prognostic Factors in 3315 Completely Resected Cases of Clinical Stage I Non-small Cell Lung Cancer in Japan Teruaki Koike, MD,* Ryosuke Tsuchiya, MD, Tomoyuki Goya, MD, Yasunori Sohara,
More informationAccepted for publication 12 August 2009 S.F.S. and G.G. are currently at Memorial Sloan-Kettering Cancer Center in New York, NY, USA
. JOURNAL COMPILATION 2009 BJU INTERNATIONAL Urological Oncology ASSOCIATION OF AGE WITH OUTCOMES OF UPPER TRACT UROTHELIAL CARCINOMA SHARIAT ET AL. BJUI BJU INTERNATIONAL Advanced patient age is associated
More informationPatient age and cutaneous malignant melanoma: Elderly patients are likely to have more aggressive histological features and poorer survival
MOLECULAR AND CLINICAL ONCOLOGY 7: 1083-1088, 2017 Patient age and cutaneous malignant melanoma: Elderly patients are likely to have more aggressive histological features and poorer survival FARUK TAS
More informationAram Kim 4, Myong Kim 1, Se Un Jeong 2, Cheryn Song 1, Yong Mee Cho 2, Jae Yoon Ro 3 and Hanjong Ahn 1*
Kim et al. BMC Urology (2018) 18:7 DOI 10.1186/s12894-018-0321-z RESEARCH ARTICLE Open Access Level of invasion into fibromuscular band is an independent factor for positive surgical margin and biochemical
More informationPrognostic Impact of Comorbidity in Patients with Bladder Cancer
available at www.sciencedirect.com journal homepage: www.europeanurology.com Bladder Cancer Prognostic Impact of Comorbidity in Patients with Bladder Cancer Ifeanyichukwu I. Megwalu a, *, Anna Vlahiotis
More informationmodels; Kaplan meier curves were also extrapolated for each cohort to compare disease specific and overall survival patterns.
; 21 Urological Oncology MUSCULARIS PROPRIA AND UPSTAGING OF ct1 BLADDER CANCER BADALATO ET AL. BJUI Does the presence of muscularis propria on transurethral resection of bladder tumour specimens affect
More informationInternational Journal of Health Sciences and Research ISSN:
International Journal of Health Sciences and Research www.ijhsr.org ISSN: 2249-9571 Original Research Article Outcome of Open Radical Cystectomy and Ileal Conduit: A Single Center Experience Mahesh Kalloli
More informationBJUI. Principal component analysis based pre-cystectomy model to predict pathological stage in patients with clinical organ-confined bladder cancer
BJUI BJU INTERNATIONAL Principal component analysis based pre-cystectomy model to predict pathological stage in patients with clinical organ-confined bladder cancer Hamed Ahmadi, Anirban P. Mitra *, George
More informationCorrespondence should be addressed to Taha Numan Yıkılmaz;
Advances in Medicine Volume 2016, Article ID 8639041, 5 pages http://dx.doi.org/10.1155/2016/8639041 Research Article External Validation of the Cancer of the Prostate Risk Assessment Postsurgical Score
More informationOutcome after emergency surgery in patients with a free perforation caused by gastric cancer
experimental and therapeutic medicine 1: 199-203, 2010 199 Outcome after emergency surgery in patients with a free perforation caused by gastric cancer Hironori Tsujimoto 1, Shuichi Hiraki 1, Naoko Sakamoto
More informationAlthough the international TNM classification system
Prognostic Significance of Perioperative Serum Carcinoembryonic Antigen in Non-Small Cell Lung Cancer: Analysis of 1,000 Consecutive Resections for Clinical Stage I Disease Morihito Okada, MD, PhD, Wataru
More informationLong-Term Risk of Clinical Progression After Biochemical Recurrence Following Radical Prostatectomy: The Impact of Time from Surgery to Recurrence
EUROPEAN UROLOGY 59 (2011) 893 899 available at www.sciencedirect.com journal homepage: www.europeanurology.com Platinum Priority Prostate Cancer Editorial by Bertrand D. Guillonneau and Karim Fizazi on
More informationXiang Hu*, Liang Cao*, Yi Yu. Introduction
Original Article Prognostic prediction in gastric cancer patients without serosal invasion: comparative study between UICC 7 th edition and JCGS 13 th edition N-classification systems Xiang Hu*, Liang
More informationValidation of the T descriptor in the new 8th TNM classification for non-small cell lung cancer
Original Article Validation of the T descriptor in the new 8th TNM classification for non-small cell lung cancer Hee Suk Jung 1, Jin Gu Lee 2, Chang Young Lee 2, Dae Joon Kim 2, Kyung Young Chung 2 1 Department
More informationUrologic Oncology: Seminars and Original Investigations xx (2010) xxx. Original article
Urologic Oncology: Seminars and Original Investigations xx (2010) xxx Original article Macroscopic sessile tumor architecture is a pathologic feature of biologically aggressive upper tract urothelial carcinoma
More informationProposed All Wales Vulval Cancer Guidelines. Dr Amanda Tristram
Proposed All Wales Vulval Cancer Guidelines Dr Amanda Tristram Previous FIGO staging FIGO Stage Features TNM Ia Lesion confined to vulva with
More informationKoji Ichihara Hiroshi Kitamura Naoya Masumori Fumimasa Fukuta Taiji Tsukamoto
Int J Clin Oncol (2013) 18:75 80 DOI 10.1007/s10147-011-0346-8 ORIGINAL ARTICLE Transurethral prostate biopsy before radical cystectomy remains clinically relevant for decision-making on urethrectomy in
More informationRadical Perineal Prostatectomy and Simultaneous Extended Pelvic Lymph Node Dissection via the Same Incision
european urology 52 (2007) 384 388 available at www.sciencedirect.com journal homepage: www.europeanurology.com Surgery in Motion Radical Perineal Prostatectomy and Simultaneous Extended Pelvic Lymph Node
More information